Meeder Asset Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,452
| Closed | -$37.2K | – | 550 |
|
|
2023
Q1 | $37.2K | Buy |
20,452
+1,100
| +6% | +$2K | ﹤0.01% | 451 |
|
|
2022
Q4 | $98.1K | Sell |
19,352
-36,812
| -66% | -$187K | 0.01% | 479 |
|
|
2022
Q3 | $279K | Buy |
56,164
+16,923
| +43% | +$84.1K | 0.02% | 506 |
|
|
2022
Q2 | $146K | Buy |
+39,241
| New | +$146K | 0.01% | 662 |
|
|
2021
Q2 | – | Sell |
-184
| Closed | -$4K | – | 2577 |
|
|
2021
Q1 | $4K | Buy |
+184
| New | +$4K | ﹤0.01% | 1913 |
|
|
2020
Q4 | – | Sell |
-7,782
| Closed | -$54K | – | 2032 |
|
|
2020
Q3 | $54K | Buy |
+7,782
| New | +$54K | ﹤0.01% | 942 |
|
|
2020
Q1 | – | Sell |
-2,024
| Closed | -$8K | – | 2409 |
|
|
2019
Q4 | $8K | Sell |
2,024
-2,568
| -56% | -$10.2K | ﹤0.01% | 1626 |
|
|
2019
Q3 | $6K | Buy |
4,592
+3,060
| +200% | +$4K | ﹤0.01% | 1697 |
|
|
2019
Q2 | $2K | Sell |
1,532
-1,100
| -42% | -$1.44K | ﹤0.01% | 1861 |
|
|
2019
Q1 | $4K | Buy |
+2,632
| New | +$4K | ﹤0.01% | 1439 |
|
|
2018
Q4 | – | Sell |
-1,370
| Closed | -$5K | – | 1749 |
|
|
2018
Q3 | $5K | Buy |
+1,370
| New | +$5K | ﹤0.01% | 1329 |
|
|
2018
Q1 | – | Sell |
-952
| Closed | -$4K | – | 1636 |
|
|
2017
Q4 | $4K | Buy |
952
+575
| +153% | +$2.42K | ﹤0.01% | 1361 |
|
|
2017
Q3 | $2K | Hold |
377
| – | – | ﹤0.01% | 1455 |
|
|
2017
Q2 | $3K | Sell |
377
-1,328
| -78% | -$10.6K | ﹤0.01% | 1324 |
|
|
2017
Q1 | $6K | Hold |
1,705
| – | – | ﹤0.01% | 1008 |
|
|
2016
Q4 | $10K | Buy |
+1,705
| New | +$10K | ﹤0.01% | 754 |
|